A citation-based method for searching scientific literature

Annette Haacke, Sarah A Broadley, Raina Boteva, Nikolay Tzvetkov, F Ulrich Hartl, Peter Breuer. Hum Mol Genet 2006
Times Cited: 93



Nihar Ranjan Jana, Priyanka Dikshit, Anand Goswami, Svetlana Kotliarova, Shigeo Murata, Keiji Tanaka, Nobuyuki Nukina. J Biol Chem 2005
Times Cited: 232




List of shared articles



Times cited

Polyglutamine diseases: where does toxicity come from? what is toxicity? where are we going?
Toshiaki Takahashi, Shinichi Katada, Osamu Onodera. J Mol Cell Biol 2010
104


Roles of Post-translational Modifications in Spinocerebellar Ataxias.
Linlin Wan, Keqin Xu, Zhao Chen, Beisha Tang, Hong Jiang. Front Cell Neurosci 2018
8



From pathways to targets: understanding the mechanisms behind polyglutamine disease.
Jonasz Jeremiasz Weber, Anna Sergeevna Sowa, Tina Binder, Jeannette Hübener. Biomed Res Int 2014
34

The DNAJB6 and DNAJB8 protein chaperones prevent intracellular aggregation of polyglutamine peptides.
Judith Gillis, Sabine Schipper-Krom, Katrin Juenemann, Anna Gruber, Silvia Coolen, Rian van den Nieuwendijk, Henk van Veen, Hermen Overkleeft, Joachim Goedhart, Harm H Kampinga,[...]. J Biol Chem 2013
68

Toward understanding Machado-Joseph disease.
Maria do Carmo Costa, Henry L Paulson. Prog Neurobiol 2012
157

Chaperones in Polyglutamine Aggregation: Beyond the Q-Stretch.
E F E Kuiper, Eduardo P de Mattos, Laura B Jardim, Harm H Kampinga, Steven Bergink. Front Neurosci 2017
23


Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.
Carlos A Matos, Sandra de Macedo-Ribeiro, Ana Luísa Carvalho. Prog Neurobiol 2011
89

Ataxin-3 protein and RNA toxicity in spinocerebellar ataxia type 3: current insights and emerging therapeutic strategies.
Melvin M Evers, Lodewijk J A Toonen, Willeke M C van Roon-Mom. Mol Neurobiol 2014
48

Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis.
Clévio Nóbrega, Ana Teresa Simões, Joana Duarte-Neves, Sónia Duarte, Ana Vasconcelos-Ferreira, Janete Cunha-Santos, Dina Pereira, Magda Santana, Cláudia Cavadas, Luís Pereira de Almeida. Adv Exp Med Biol 2018
9

Machado-Joseph disease/spinocerebellar ataxia type 3: lessons from disease pathogenesis and clues into therapy.
Carlos A Matos, Luís Pereira de Almeida, Clévio Nóbrega. J Neurochem 2019
39

From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation.
Jorge Diogo Da Silva, Andreia Teixeira-Castro, Patrícia Maciel. Neurotherapeutics 2019
16


Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity.
Marcel Raspe, Judith Gillis, Hilde Krol, Sabine Krom, Klazien Bosch, Henk van Veen, Eric Reits. J Cell Sci 2009
42

Post-translational modifications of expanded polyglutamine proteins: impact on neurotoxicity.
Maria Pennuto, Isabella Palazzolo, Angelo Poletti. Hum Mol Genet 2009
56

Proteolytic Cleavage of Polyglutamine Disease-Causing Proteins: Revisiting the Toxic Fragment Hypothesis.
Carlos A Matos, Luis Pereira de Almeida, Clevio Nobrega. Curr Pharm Des 2017
16